Business, energy, technology, markets and global industry news from Business News Today
PharmaDeviceNews
Mevion’s S250-FIT arrives in Europe with a sharper pitch for proton therapy access
Medical Devices & Diagnostics

Can Mevion’s S250-FIT make proton therapy practical for more cancer centers?

Proton therapy has long had an infrastructure problem. Mevion’s S250-FIT asks whether existing LINAC vaults can change that.

Read More
Representative image: A modern dermatology research laboratory scene illustrating Almirall’s Q1 2026 growth momentum, as Ebglyss and Ilumetri strengthen its biologics-led medical dermatology strategy in Europe.
Pharma & Biotech

Can Almirall turn dermatology momentum into a stronger long-term innovation engine?

Almirall’s dermatology engine is growing faster than group sales. The next test is whether biologics and pipeline bets can sustain momentum.

Read More
Representative image: Niagen Bioscience’s investor conference push highlights the growing commercial debate around NAD+ science, healthy aging, Tru Niagen, Niagen Plus, and whether healthspan-focused platforms can convert clinical credibility into durable market confidence.
Pharma & Biotech

Why Niagen Bioscience’s next investor meetings could sharpen the NAD+ market debate

NAD+ is hot, but credibility is scarce. Niagen Bioscience now has to prove healthspan science can support durable investor trust.

Read More
Representative image: A wearable health platform displays biometric trends, AI coaching insights, and a virtual clinician consultation, reflecting WHOOP’s push into connected digital health, on-demand clinical support, and personalized wellness intelligence.
Medical Devices & Diagnostics

Is WHOOP quietly turning its fitness band into a front door for healthcare?

Wearables collect more health data than ever. WHOOP is betting clinicians and AI can turn that flood into real decisions.

Read More
Representative image of a precision retina surgery procedure using advanced vitrectomy technology, reflecting Bausch + Lomb’s Bi-Blade+ launch in Europe and the growing focus on surgical control, fluidics stability and vitreoretinal workflow efficiency.
Medical Devices & Diagnostics

Can Bi-Blade+ strengthen Bausch + Lomb’s position in European retina surgery?

A faster cutter is only part of the story. Bausch + Lomb’s Bi-Blade+ launch tests whether surgical platform upgrades can drive loyalty.

Read More
Representative image: A clinician reviews liver imaging in an oncology treatment setting, reflecting Delcath Systems’ liver-directed melphalan strategy for liver-dominant metastatic breast cancer and the growing clinical focus on targeted hepatic cancer therapies.
Pharma & Biotech

Delcath Systems tests whether HEPZATO KIT can move beyond metastatic uveal melanoma

Delcath has a liver-response signal in breast cancer. The harder test is whether HEPZATO KIT can prove value beyond a small cohort.

Read More
Representative image of an advanced neurovascular stroke procedure, illustrating how Rapid Medical’s TIGERTRIEVER 13 DISTALS trial data could support wider interest in small-vessel thrombectomy for distal and medium vessel occlusion stroke.
Medical Devices & Diagnostics

Why Rapid Medical’s DISTALS data could reshape treatment expectations in smaller stroke vessels

Distal stroke has long lacked device options. Rapid Medical’s TIGERTRIEVER 13 data now tests whether small-vessel thrombectomy can scale.

Read More
Representative image: A dry powder inhaler prototype is shown in a pharmaceutical research setting, reflecting Phillips Medisize’s focus on connected inhaler innovation, device-formulation alignment, and patient-centric respiratory drug delivery at RDD 2026.
Medical Devices & Diagnostics

Phillips Medisize targets formulation-device risk as inhaled therapies grow more complex

Inhalers are getting smarter, but complexity can backfire. Phillips Medisize is betting DPI success starts with patient-centric design.

Read More
Representative image: A clinical research scene showing atopic dermatitis assessment, reflecting TRexBio’s TRB-061 development strategy as TNFR2 agonism and tissue Treg biology emerge as potential new approaches for treating moderate-to-severe inflammatory skin disease.
Pharma & Biotech

Could TRexBio’s Treg bet crack the next big frontier in atopic dermatitis?

Atopic dermatitis has more drugs, but not enough durable control. TRexBio’s TRB-061 tests whether tissue Tregs can change that.

Read More
Representative image of an advanced endoscopy suite, illustrating how Fujifilm’s ELUXEO 8000 imaging system and EG-840TP gastroscope highlight the growing role of precision visualization in minimally invasive gastrointestinal procedures.
Medical Devices & Diagnostics

Fujifilm’s ELUXEO 8000 and EG-840TP pairing raises the bar in interventional endoscopy

Advanced GI procedures need better visualization. Fujifilm’s ELUXEO 8000 win shows why imaging may decide adoption.

Read More